A new report released by Clean Production Action provides the first ever chemical footprint of products commonly used in pediatric patient rooms. Hazardous chemicals in products are catalyzing health care organizations to ask suppliers whether or not their products contain these chemicals. The report assessed the chemical footprint – the presence of hazardous chemicals – of over 250 products commonly found in a hospital pediatric patient room.
Hazardous chemicals “present reputational, regulatory, and reformulation risks across a broad range of industry sectors. Investors need to understand how companies are meaningfully managing these risks.”
CFP is a market differentiator and provides a competitive advantage for business leaders. This new tool will add a level of transparency and help companies mitigate reputational and regulatory risks and exploit opportunities afforded by moving to safer chemicals.
We see the Chemical Footprint Project enabling us to quickly recognize and reward suppliers for doing what matters most to us in health care, which is implementing systems to ensure their products and supply chains use safe and healthy chemical ingredients
Companies need to know the chemicals in their products and supply chains, and be able to benchmark their performance. CFP offers a new and welcomed option for companies to make progress in these efforts.
The Investor Environmental Health Network welcomes the launch of the Chemical Footprint Project. For too long chemicals and health have been missing pieces in Environmental Social Governance (ESG) assessments. Now we have a tool that investors can use to fill in this critical information.